Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05684367 · ClinicalTrials.gov registry record · NA

Exercise to ReGain Stamina and Energy (The EXERGISE Study)

A NA study of Breast Cancer and Fatigue, sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT05684367 is a NA study of Breast Cancer and Fatigue that is actively recruiting participants, run by University of Florida. The registered enrollment target is 24 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05684367, a NA study of Breast Cancer and Fatigue, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

About 20%-70% of breast cancer survivors experience fatigue after cancer therapy. Because epidemiologic evidence shows that old age is a risk factor for fatigue in adults with cancer history, older breast cancer survivors suffer from even more fatigue than younger survivors. The purpose of this study is to test types of walking exercise interventions and their ability to reduce fatigue in older breast cancer survivors.

Interventions

  • BEHAVIORAL Center-Based Walking Exercise
  • BEHAVIORAL Home-Based Walking Exercise

Study Locations (1)

Florida

  • Institute on Aging; University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2023-11-29
Est. Completion 2026-08
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT05684367

The ClinicalTrials.gov registry entry for NCT05684367 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Center-Based Walking Exercise is the first listed.

NCT05684367 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05684367 about?

NCT05684367 is a clinical study titled "Exercise to ReGain Stamina and Energy (The EXERGISE Study)". About 20%-70% of breast cancer survivors experience fatigue after cancer therapy. Because epidemiologic evidence shows that old age is a risk factor for fatigue in adults with cancer history, older breast cancer survivors suffer from even more fatigue than younger survivors. The purpose of this stud...

What is the current status of trial NCT05684367?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2023-11-29. Estimated completion is 2026-08.

What conditions does trial NCT05684367 study?

This clinical trial studies the following conditions: Breast Cancer, Fatigue, Cancer, Therapy-Related.

What interventions are being tested in trial NCT05684367?

The interventions under investigation include: Center-Based Walking Exercise (BEHAVIORAL), Home-Based Walking Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT05684367?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05684367 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.